Greater weight loss was linked to lower discontinuation rates, with a 1% reduction in weight lowering the hazard of ...

A high-resolution spatial map of the human hypothalamus makes it possible to identify specific cells, determine their exact ...

Obesity is a growing concern worldwide, including in low- and middle-income countries (LMICs). Addressing this issue involves various strategies, including dietary and lifestyle changes, medical ...

The Princeton-based startup said the move was related to “a revenue mix shift within the Noom business" driven by a change in ...

"I would argue that GLP-1 for dietitians is the biggest tailwind that any single provider type in American health care has ...

LifeVantage (LFVN) announced the completion of an international in vitro cell study that investigated the effects of its international ...

Rani Therapeutics (RANI) announced new pharmacokinetic and pharmacodynamic data from a preclinical study evaluating the oral delivery of the ...

Novo Nordisk's CEO is not worried about blockbuster semaglutide drugs being added to Medicare drug pricing negotiations this ...

Too many young people are prescribed pills for mental illness. Are we repeating history with GLP-1s?

A small percentage of patients taking GLP-1 medications have experienced vision problems, but a direct causal link with the ...

A randomized controlled trial demonstrated a significantly reduced incidence of type 2 diabetes among individuals with metabolic syndrome who received daily metformin with or without a Mediterranean ...

Many Americans have flocked to cheaper, compounded versions of GLP-1 weight loss drugs in lieu of brand-name treatments. That ...